Fluid bolus study reveals how IV fluids impact heart and brain in low blood volume

NCT ID NCT05705115

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study in 15 healthy volunteers tested how a small amount of Ringer's acetate (a common IV fluid) affects heart function and brain blood flow when blood volume is low. Participants were given the fluid during both normal and low blood volume conditions (simulated using lower body suction). The goal was to measure how long the fluid's effects last. The findings may help guide fluid therapy in hospitals.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Ringer's acetate (intravenous fluid)
What this could lead to
If successful, this could help doctors better understand how and when to give IV fluids to patients with low blood volume, improving treatment decisions.
What could go wrong
This is a small, early-phase study in healthy volunteers, not patients. Results may not apply to real-world medical situations, and the fluid's effects may be short-lived.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FLUID LOSS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hypovolemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Oslo University Hospital

    Oslo, Oslo, 0586, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.